Use careArticle link

Focused Ultrasound: Opening the Blood-Brain Barrier for Alzheimer’s Treatment

Focused ultrasound is an experimental technique that temporarily opens the blood-brain barrier to allow more Alzheimer’s medication to reach the brain. Early results suggest it can increase drug delivery by about 50%, helping break up amyloid plaques. While promising, it carries risks like microhemorrhages and is only available in clinical trials. This guide explains how it works, what to expect, and how to discuss it with your loved one’s care team.

Key points

  • Focused ultrasound temporarily opens the blood-brain barrier, allowing about 50% more Alzheimer’s drug to reach the brain.
  • It is still experimental and only available in clinical trials—not a standard treatment.
  • Risks include microhemorrhages, stroke, and temporary headaches; genetic testing (APOE) helps assess risk.
  • The procedure does not cure Alzheimer’s but may help slow plaque buildup.
  • Use TrialMatch to find studies, and always bring a list of questions to the consultation.
  • Keep a symptom journal and report any new changes immediately to the trial team.

What Is the Blood-Brain Barrier and Why Does It Matter?

Your brain is protected by a natural filter called the blood-brain barrier. This barrier keeps harmful substances in your blood from entering the brain, but it also blocks many medications, including those used for Alzheimer’s. For years, this has been a major hurdle: even when a drug is injected into your veins, only a tiny fraction actually reaches the brain tissue where it’s needed. Focused ultrasound is a way to gently and temporarily open this barrier, allowing more of the drug to get through.

How Does Focused Ultrasound Work?

During the procedure, you lie inside an MRI scanner that guides a helmet-like device. The device sends hundreds of low-intensity ultrasound beams to a precise spot in your brain. These beams are focused like a magnifying glass concentrates sunlight. At the target, the ultrasound energy causes tiny bubbles in your bloodstream to vibrate, gently pushing apart the cells of the blood-brain barrier. This opening lasts for a few hours, during which the Alzheimer’s drug is given intravenously. The barrier then closes back up on its own. Early studies show that this method can get about 50% more of the drug into the brain compared to IV alone.

What Are the Potential Benefits and Risks?

The main benefit is that more medication reaches the brain, which may help break up amyloid plaques more effectively. However, it’s important to understand that this does not reverse Alzheimer’s—the disease process continues. The procedure itself is noninvasive and typically done as an outpatient. Risks include small microhemorrhages (tiny bleeds visible on scans) and, in rare cases, larger strokes. Some participants have experienced temporary headaches or dizziness. Because this is still experimental, all risks must be discussed thoroughly with the clinical trial team.

General caregiving information, not medical advice. Check medications and major care changes with your clinician.

Step-by-step

  1. Ask your loved one's neurologist about focused ultrasound clinical trials, or search the Alzheimer's Association's TrialMatch tool (alz.org/trialmatch) to find studies near you.

  2. At the consultation, the study team will review your loved one's full medical history—including any history of stroke, bleeding disorders, or blood thinners—and schedule baseline tests: an MRI, cognitive assessments, and possibly APOE genetic testing.

  3. On procedure day, your loved one will be positioned in the MRI scanner with the ultrasound helmet on their head, likely awake with a mild sedative, while the team uses real-time MRI to guide focused ultrasound beams for about 30–60 minutes.

  4. Immediately after the ultrasound opens the blood-brain barrier, the Alzheimer's drug (such as lecanemab or donanemab) is infused over about an hour.

  5. Afterward, your loved one will be monitored for several hours, with a follow-up MRI the next day to check for microhemorrhages or swelling; plan a quiet day at home, as some people feel tired or get a mild headache.

  6. Attend every follow-up visit, where the team will repeat cognitive tests and brain scans every few months. Keep a simple journal of any new symptoms—confusion, one-sided weakness, vision changes, persistent headache—and report them to the trial team right away.

What not to do

  • Do not assume focused ultrasound is a cure. It helps medications work better, but Alzheimer's continues to progress.

  • Do not skip the APOE genetic testing discussion if it's offered, as it helps gauge the risk of brain swelling or bleeding.

  • Do not stop your loved one's current medications—especially blood thinners—without first talking to the trial team; some drugs may need to be paused only under medical supervision.

  • Do not ignore new symptoms after the procedure; even mild changes like a persistent headache or slight confusion deserve a call to the trial team.

  • Do not expect insurance to cover the procedure; focused ultrasound for Alzheimer's is experimental and only available in clinical trials—costs are usually covered by the study sponsor, but travel and lodging often are not.

  • Do not overlook what happens when the trial ends; ask upfront whether your loved one can continue treatment, will transition to standard care, or needs a long-term monitoring plan.

Practical tools

  • TrialMatch Search Tool

    Use the Alzheimer's Association's free TrialMatch service (alz.org/trialmatch) to find focused ultrasound studies. Filter by location, disease stage, and treatment type, and connect directly with study coordinators.

  • Questions to Ask the Trial Team

    Print this list and bring it to your consultation: 1) How many participants have been treated so far? 2) What were the most common side effects? 3) How long is the trial and what follow-up is required? 4) Will genetic testing be done? 5) What happens if my loved one has a serious side effect? 6) Is there a placebo group? 7) Are travel costs reimbursed? 8) What happens when the trial ends?

  • Symptom Tracking Journal

    Keep a simple daily log of mood, energy, appetite, and any new physical symptoms, noting the date and time. This helps the trial team spot early warning signs and gives you a clear record to reference at each visit.

  • Medical Power of Attorney Document

    Before enrolling, ensure your loved one has a medical power of attorney in place so you can make decisions if they're unable; have it drafted or reviewed by an elder law attorney.

  • Caregiver Support Group

    Connect with other caregivers of people in Alzheimer's clinical trials—the Alzheimer's Association's 24/7 helpline (800-272-3900) and local chapters can help you find one; sharing experiences can reduce anxiety and surface practical tips.

Discuss with your clinician

Ask your neurologist: Is my loved one’s APOE gene status known, and how would it affect the risk of brain swelling or bleeding from focused ultrasound?

Ask the trial team: What is the specific protocol for managing microhemorrhages or larger strokes if they occur?

Ask the pharmacist: Will the Alzheimer’s drug used in the trial interact with any of my loved one’s current medications, especially blood thinners or antidepressants?

Ask the primary care doctor: Should we pause any medications before the procedure, and if so, for how long?

Ask the trial coordinator: Are there any out-of-pocket costs for travel, lodging, or follow-up scans that we should expect?

Related guides

Sources